Abstract
According to National Health Data (2015), spending on pharmaceuticals in Kazakhstan (US$ 34 per capita in PPP). The pharmaceutical expenditure in Kazakhstan is 1.04% of GDP compared to 1.5% GDP in the OECD, or 14% of total health care spending versus 16% in the OECD. The Ministry of Health is responsible for determining which pharmaceuticals are reimbursed. Decisions regarding the reimbursement level are made once the maximum price has been established.